Probiotic 30 Billion
Natural health product licensed in Canada
- Other names
- Probiotic 30 Billion Extra Strength
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80076773
- Status
- Active licence
- Licence date
- 18 April 2017
- Revision date
- 18 August 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. infantis Source : UABi-13 | 0.03 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 0.03 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : UALR-06 | 3 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : UALr-18 | 3 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 1.5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : DDS-1 | 1.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 1.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : UALP-05 | 1.5 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 0.9 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : UABB-10 | 0.9 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : UALc-03 | 0.9 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Cellule entière | 0.9 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : Cellule entière | 4.5 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : UALpc04 | 4.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : UABL-14 | 1.17 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 1.17 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 6 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : UABLA-12 | 6 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : UABbr11 | 3 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : UALG-05 | 3 Milliards d'UFC | Not calculated |
| Lactobacillus reuteri Source : UALre-16 | 0.9 Milliards d'UFC | Not calculated |
| Lactobacillus reuteri Source : Cellule entière | 0.9 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : UALl-08 | 0.6 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : Cellule entière | 0.6 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Sucrose, Ascorbate de sodium, Silica, Stéarate de magnésium, Maltodextrine, Phosphate de potassium monobasique, Sulfate de magnésium, Chlorure de sodium, L-aspartate de sodium, Hypromellose, Citrate de sodium, Phosphate de dipotassium, Inuline, Dextrose, Trehalose, Gomme arabique (acacia)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 3 years ; maximum: 5 years | 1 Capsule | 1 Tous les jours |
| Adultes, adolescents et enfants | minimum: 6 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote a favourable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have fever, vomiting, bloody diarrhea or severe abdominal pain. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80076773
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.